We are live on ! Find out more
MAM

Monaco Asset Management Portfolio holdings

AUM $542M
1-Year Est. Return 54.4%
This Fund
S&P 500
This Quarter Est. Return
+2.05%
1 Year Est. Return
+54.4%
3 Year Est. Return
+96.99%
5 Year Est. Return
10 Year Est. Return
AUM
$570M
AUM Growth
+$80.7M
Cap. Flow
+$36.6M
Cap. Flow %
6.41%
Top 10 Hldgs %
61.05%
Holding
110
New
34
Increased
25
Reduced
22
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 13.38%
2 Materials 11.28%
3 Energy 7.1%
4 Communication Services 6.23%
5 Consumer Discretionary 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTYX
51
DELISTED
Ventyx Biosciences
VTYX
$1.63M 0.29%
761,891
-372,553
-33% -$602K
BG icon
52
Bunge Global
BG
$21.3B
$1.61M 0.28%
20,000
+16,889
+543% +$1.33M
NVAX icon
53
Novavax
NVAX
$1.22B
$1.45M 0.25%
230,000
-60,000
-21% -$397K
VNDA icon
54
Vanda Pharmaceuticals
VNDA
$303M
$1.44M 0.25%
305,000
-20,000
-6% -$87.5K
DNA icon
55
Ginkgo Bioworks
DNA
$519M
$1.41M 0.25%
125,000
-52,500
-30% -$407K
CYTK icon
56
Cytokinetics
CYTK
$10.8B
$1.4M 0.25%
+42,500
New +$1.48M
ETSY icon
57
Etsy
ETSY
$8.24B
$1.25M 0.22%
+25,000
New +$1.24M
INGN icon
58
Inogen
INGN
$175M
$1.25M 0.22%
177,594
+10,000
+6% +$67.2K
PAAS icon
59
Pan American Silver
PAAS
$18.3B
$1.15M 0.2%
40,468
-254,532
-86% -$6.59M
NKTR icon
60
Nektar Therapeutics
NKTR
$2.4B
$1.14M 0.2%
43,966
-27,294
-38% -$306K
INTC icon
61
Intel
INTC
$435B
$1.12M 0.2%
+50,000
New +$1.04M
RCKT icon
62
Rocket Pharmaceuticals
RCKT
$343M
$1.11M 0.19%
+452,767
New +$2.29M
MREO
63
Mereo BioPharma
MREO
$51.9M
$1.07M 0.19%
395,000
-21,468
-5% -$51.8K
DVS
64
DELISTED
Dolly Varden Silver Corp
DVS
$1.02M 0.18%
+305,600
New +$914K
LKFT
65
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$1.01M 0.18%
36,036
QURE icon
66
uniQure
QURE
$2.81B
$976K 0.17%
70,000
-5,000
-7% -$67.3K
FET icon
67
Forum Energy Technologies
FET
$582M
$974K 0.17%
50,000
-2,206
-4% -$35.7K
DVN icon
68
Devon Energy
DVN
$51.2B
$954K 0.17%
+30,000
New +$955K
GRWG icon
69
GrowGeneration
GRWG
$86.5M
$950K 0.17%
1,015,743
+467,022
+85% +$498K
PRQR icon
70
ProQR Therapeutics
PRQR
$253M
$938K 0.16%
460,000
-11,908
-3% -$19.4K
BMA icon
71
Banco Macro
BMA
$5.88B
$913K 0.16%
13,000
+9,000
+225% +$744K
QTTB icon
72
Q32 Bio
QTTB
$458M
$882K 0.15%
591,937
+86,486
+17% +$147K
PLRX icon
73
Pliant Therapeutics
PLRX
$66.3M
$815K 0.14%
+702,393
New +$992K
SDGR icon
74
Schrodinger
SDGR
$1.14B
$805K 0.14%
40,000
-42,500
-52% -$970K
FATE icon
75
Fate Therapeutics
FATE
$282M
$756K 0.13%
675,000
-474,708
-41% -$552K

Similar funds

Monaco Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Monaco Asset Management held 110 positions worth $570M, up 16% from $490M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Monaco Asset Management deployed $36.6M of net new capital in Q2 2025, opening 34 new positions and adding to 25 existing holdings. Its largest new stake was Perpetua Resources: 1,043,000 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Materials and Energy.

On the sell side, the largest reduction was MAG Silver, an estimated $7.66M trimmed.

  • Monaco Asset Management's largest Q2 2025 buy was Perpetua Resources: 1,043,000 shares worth $12.7M.
  • Monaco Asset Management added most to Patterson-UTI in Q2 2025, an estimated $16.1M increase.
  • Monaco Asset Management's biggest Q2 2025 reduction was MAG Silver, cutting an estimated $7.66M.
  • Monaco Asset Management fully exited PayPal in Q2 2025, selling an estimated $2.94M.
  • Monaco Asset Management's ten largest holdings make up 61% of its $570M portfolio in Q2 2025.
  • Monaco Asset Management opened 34 new positions and closed 19 in Q2 2025.
  • Monaco Asset Management's portfolio value rose 16% quarter-over-quarter to $570M.

Based on Monaco Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.